Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a new platform release. This change represents a version upgrade to the ClinicalTrials.gov interface rather than any modification to study content or data.
    Difference
    0.1%
    Check dated 2026-05-16T09:06:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    This reflects an update to the site/app revision number for the page display (moving from revision v3.5.2 to v3.5.3), with no indication of any content changes to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T17:09:33.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:01:49.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The site revision label was updated to v3.5.0 and the previous label v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:21:46.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T20:40:03.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The two screenshots show no detectable differences in the page content. Study design, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T18:08:55.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.